U.S. News: City of Hope Is Best Cancer Hospital in the West

July 29, 2019 | Letisia Marquez

City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.

Continue Reading

A blood test for cancer? New department focuses on early detection

September 19, 2019 | Maxine Nunes

Dynamic and passionate — with a formidable track record of innovations in cancer care — Ajay Goel, Ph.D., M.S., has recently joined the staff at City of Hope, and he’s hit the ground running.

Certain colorectal patients may benefit from immunotherapy

September 16, 2019 | Zen Vuong

People with colon and rectal tumors prone to “immune overdrive” don’t do well if they concurrently have an immune-suppressive tumor microenvironment, City of Hope researchers say.

Cancer screening guidance from City of Hope experts

August 16, 2019 | Samantha Bonar

August 16 is National Cancer Screening Day for breast, cervical and colorectal cancer. The day is an effort to increase awareness and education for breast, cervical and colorectal cancers.

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Colorectal tumor biomarker may predict immunotherapy effectiveness

May 2, 2019 | Zen Vuong

The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.

Study finds cancer rate rising in millennials

March 6, 2019 | Dory Benford

A new study by the American Cancer Society finds rates of obesity-related cancers — including colorectal, endometrial, pancreatic, kidney, gallbladder and multiple myeloma — rising among young people.